Center-Authored Papers

Filters: Author is Margolin, Kim  [Clear All Filters]
2011
Lee S, Margolin K.  2011.  Cytokines in cancer immunotherapy.. Cancers. 3(4):3856-93. Abstract
Othus M, Moon J, Margolin K.  2011.  Melanoma's deadly march to the brain: by what route, and can it be stopped? Cancer. 117(8):1560-3.
2012
Lee S, Margolin K.  2012.  Tumor-infiltrating lymphocytes in melanoma.. Current oncology reports. 14(5):468-74. Abstract
2013
Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M et al..  2013.  Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".. Journal of translational medicine. 11:137. Abstract
Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge RD, Chang SM, Dancey J, Gaspar LE et al..  2013.  Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.. The lancet oncology. 14(10):e396-406. Abstract
2014
Ascierto PA, Margolin K.  2014.  Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.. Cancer.
Flaherty L, Hamid O, Linette G, Schuchter L, Hallmeyer S, Gonzalez R, Cowey LC, Pavlick A, Kudrik F, Curti B et al..  2014.  A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.. Cancer journal (Sudbury, Mass.). 20(1):18-24. Abstract
Margolin K.  2014.  Introduction to the Role of the Immune System in Melanoma.. Hematology/oncology clinics of North America. 28(3):537-558. Abstract
2015
Schadendorf D, Hodi SF, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen T-T, Berman DM, Wolchok JD.  2015.  Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Di Giacomo AM, Margolin K.  2015.  Immune Checkpoint Blockade in Patients With Melanoma Metastatic to the Brain.. Seminars in oncology. 42(3):459-465. Abstract
2016
Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP et al..  2016.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.. The New England journal of medicine. Abstract
Bhatia S, Margolin K.  2016.  Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!. Cancer.
2018
Margolin K, Morishima C, Velcheti V, Miller JS, Lee SM, Silk AW, Holtan SG, Lacroix AM, Fling SP, Kaiser JC et al..  2018.  Phase I Trial of ALT-803, a Novel Recombinant Interleukin-15 Complex, in Patients with Advanced Solid Tumors.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract